ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
Forward Looking Statements
When used in this form 10-K and in future
filings by the Company with the Commission, The words or phrases such as “anticipate,” “believe,”
“could," “would,” “should,” “estimate,” “expect,” “intend,”
“may,” “plan,” “predict,” “project,” “will,” “try” or
similar expressions are intended to identify “forward-looking statements” within the meaning of the Private
Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on any such forward looking
statements, each of which speak only as of the date made. Such statements are subject to certain risks and uncertainties
that could cause actual results to differ materially from historical earnings and those presently anticipated or
projected. The Company has no obligation to publicly release the result of any revisions which may be made to any
forward-looking statements to reflect anticipated or unanticipated events or circumstances occurring after the date of such
statements.
These forward-looking statements involve known and
unknown risks, uncertainties and other factors that may cause actual results to be materially different. These factors include, but are
not limited to, changes that may occur to general economic and business conditions; changes in current pricing levels that we can charge
for our services or which we pay to our suppliers and business partners; changes in political, social and economic conditions in the jurisdictions
in which we operate; changes to regulations that pertain to our operations; changes in technology that render our technology relatively
inferior, obsolete or more expensive
compared to others; foreign currency fluctuations; changes in the business prospects of our business
partners and customers; increased competition, including from our business partners; delays in the delivery of broadband capacity to the
homes and offices of persons who use our services; general disruptions to Internet service; and the loss of customer faith in the Internet
as a means of commerce.
The following discussion should be read in conjunction
with the financial statements and related notes which are included in this report under Item 8.
We do not undertake to update our forward-looking
statements or risk factors to reflect future events or circumstances.
Overview
Critical Accounting Policies
Basis of Presentation and Principles of Consolidation
The Company’s consolidated financial statements
and the notes thereto have been prepared in accordance with Generally Accepted Accounting Principles (“GAAP”) in the United
States of America. The consolidated financial statements include Real Brands, and its wholly owned subsidiaries. One subsidiary, Real
Brands Venture Group, LLC, has been inactive for the last two years and only maintains a debt instrument on its financial records. DePetrillo
Real Estate Holdings, LLC is a wholly owned subsidiary of CASH Acquisition Corp. and the owner of the Company’s building in Rhode
Island. American Standard Hemp Inc. is a wholly owned subsidiary of CASH Acquisition Corp. and holds the hemp licenses in Rhode Island.
All significant intercompany accounts and transactions have been eliminated.
Use of estimates and judgments
The preparation of financial statements in conformity
with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during
the reporting period. Key areas of estimation include the estimated useful lives of property, plant, equipment and intangibles assets
and liabilities, income taxes, and the valuation of stock-based compensation. Due to the uncertainty inherent in such estimates, actual
results may differ from the Company’s estimates. Accounting standard updates
From time to time, new accounting pronouncements are
issued by the Financial Accounting Standards Board (“FASB”) or other standard setting bodies that are adopted by the Company
as of the specified effective date. Unless otherwise discussed, the Company believes that the effect of recently issued standards that
are not yet effective will not have a material effect on its consolidated financial position or results of operations upon adoption.
Segment Reporting
The Company operates as one segment, in which management
uses one measure of profitability, and all of the Company’s assets are located in the United States of America. The Company does
not operate separate lines of business or separate business entities with respect to any of its product candidates. Accordingly, the Company
does not have separately reportable segments.
Cash and Cash Equivalents
The Company considers all highly liquid investments
with an original maturity of three months or less when purchased to be a cash equivalent.
Accounts Receivable and Allowance for Doubtful
Accounts
The Company performs periodic credit evaluations
of its customers’ financial conditions and generally does not require collateral. The Company reviews all outstanding accounts
receivable for collectability on a quarterly basis. An allowance for doubtful accounts is recorded for any amounts deemed uncollectable.
The Company does not accrue interest receivable on past due accounts receivable.
Concentrations of Credit Risk
The Company, from time to time during the years covered
by these consolidated financial statements, may have bank balances in excess of its insured limits. Management has deemed this a normal
business risk.
Inventory
Inventory is comprised of raw hemp and hemp oil in
different phases of production to completion of final product. Products include tinctures, creams and lotions. Inventory is valued at
cost. No packaging material of any kind is included in inventory. Packaging materials are expensed as incurred.
Property and Equipment
On February 15, 2020 the Company purchased
DePetrillo Real Estate Holdings, LLC, a Rhode Island Limited Liability Company having as it’s only asset the building at 12 Humbert
Street in North Providence Rhode Island. The building is the Company’s headquarters and a hemp processing facility. The purchase
price of the building was 2 million shares of CASH common stock, $25,000 in cash and the assumption of the mortgage which at the time
was $189,916. The prior owner agreed to put the $25,000 payment into building improvements. The building and land were appraised at $475,000.
The building is being depreciated over 15 years on a straight-line basis starting October 1, 2021. Depreciation expense on the building
for the year ended December 31, 2021 was $7,917.
The Company made $121,411 in building improvements
and purchases of $26,588 in furniture and equipment during the year ended December 31, 2021. The Company made $644,412 in building improvements
during the year ended December 31, 2020. $135,000 of those improvements were in the form of CASH common stock valued at $0.50 per share.
Building improvements is being depreciated over 15 years commencing from the completion of the work, October 1, 2021. Depreciation expense
on building improvements for the year ended December 31, 2021 was $13,097.
Property and equipment are recorded at cost. Depreciation is computed using
the straight-line method over estimated useful lives of five years. On December 31, 2021 the Company wrote down the value of the equipment
to $0 because the equipment had been sitting idle for over a year resulting in a loss on disposal of assets of $385,989. The furniture
and equipment and related accumulated depreciation were removed from the books as of December 31, 2021. Depreciation expense on the property
and equipment for the year ended December 31, 2021, before it was written off was $146,522. Total depreciation expense for the year ended
December 31, 2021 was $167,536. Expenditures for repairs and maintenance are expensed as incurred.
Impairment of Long-Lived Assets
The Company reviews long-lived assets, including property
and equipment, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may
not be fully recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance
of the business in relation to expectations, significant negative industry or economic trends, and significant changes or planned changes
in the use of the assets. If an impairment review is performed to evaluate long-lived asset for recoverability, the Company compares forecasts
of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived asset to its carrying value. An
impairment loss would be recognized when estimated undiscounted future cash flows expected to result from the use of an asset over its
fair value, determined based on discounted cash flows is less than the carrying value on the books of the Company.
Revenue Recognition
The Company follows, ASC 606 Revenue from Contracts
with Customers which establishes a single and comprehensive framework and sets out how much revenue is to be recognized, and when. The
core principle is that a vendor should recognize revenue to depict the transfer of promised goods or services to customers in an amount
that reflects the consideration to which the vendor expects to be entitled in exchange for those goods or services. Revenue will now be
recognized by a vendor when control over the goods or services is transferred to the customer. In contrast, Revenue based revenue recognition
is around an analysis of the transfer of risks and rewards; this now forms one of a number of criteria that are assessed in determining
whether control has been transferred. The application of the core principle in ASC 606 is carried out in five steps: Step 1 – Identify
the contract with a customer: a contract is defined as an agreement (including oral and implied), between two or more parties, that creates
enforceable rights and obligations and sets out the criteria for each of those rights and obligations. The contract needs to have commercial
substance and it is probable that the entity will collect the consideration to which it will be entitled. Step 2 – Identify the
performance obligations in the contract: a performance obligation in a contract is a promise (including implicit) to transfer a good or
service to the customer. Each performance obligation should be capable of being distinct and is separately identifiable in the contract.
Step 3 – Determine the transaction price: transaction price is the amount of consideration that the entity can be entitled to, in
exchange for transferring the promised goods and services to a customer, excluding amounts collected on behalf of third parties. Step
4 – Allocate the transaction price to the performance obligations in the contract: for a contract that has more than one performance
obligation, the entity will allocate the transaction price to each performance obligation separately, in exchange for satisfying each
performance obligation. The acceptable methods of allocating the transaction price include adjusted market assessment approach, expected
cost plus a margin approach, and the residual approach in limited circumstances. Discounts given should be allocated proportionately to
all performance obligations unless certain criteria are met and reallocation of changes in standalone selling prices after inception is
not permitted. Step 5 – Recognize revenue as and when the entity satisfies a performance obligation: the entity should recognize
revenue at a point in time, except if it meets any of the three criteria, which will require recognition of revenue over time: the entity’s
performance creates or enhances an asset controlled by the customer, the customer simultaneously receives and consumes the benefit of
the entity’s performance as the entity performs, and the entity does not create an asset that has an alternative use to the entity
and the entity has the right to be paid for performance to date.
Stock-based Compensation
The Company expenses stock-based compensation to employees
and consultants based on the fair value at grant date, which generally is the agreement date the Company entered into with employees or
consultants. To date the Company has issued restricted common stock shares and preferred stock.
Beneficial Conversion Features of Convertible Securities
Conversion options that are not bifurcated as a derivative
pursuant to ASC 815 and not accounted for as a separate equity component under the cash conversion guidance are evaluated to determine
whether they are beneficial to the investor at inception (a beneficial conversion feature) or may become beneficial in the future due
to potential adjustments. The beneficial conversion feature guidance in ASC 470-20 applies to convertible stock as well as convertible
debt which are outside the scope of ASC 815. A beneficial conversion feature is defined as a nondetachable conversion feature that is
in the money at the commitment date. The beneficial conversion feature guidance requires recognition of the conversion option’s
in-the-money portion, the intrinsic value of the option, in equity, with an offsetting reduction to the carrying amount of the instrument.
The resulting discount is amortized as a dividend over either the life of the instrument, if a stated maturity date exists, or to the
earliest conversion date, if there is no stated maturity date. If the earliest conversion date is immediately upon issuance, the dividend
must be recognized at inception. When there is a subsequent change to the conversion ratio based on a future occurrence, the new conversion
price may trigger the recognition of an additional beneficial conversion feature on occurrence.
Derivatives
The Company reviews the terms of convertible debt
issued to determine whether there are embedded derivative instruments, including embedded conversion options, which are required to be
bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more
than one embedded derivative instrument, including the conversion option, that is required to be bifurcated, the bifurcated derivative
instruments are accounted for as a single, compound derivative instrument.
Bifurcated embedded derivatives are initially recorded
at fair value and are then revalued at each reporting date with changes in the fair value reported as non-operating income or expense.
When the equity or convertible debt instruments contain embedded derivative instruments that are to be bifurcated and accounted for as
liabilities, the total proceeds received are first allocated to the fair value of all the bifurcated derivative instruments. The remaining
proceeds, if any, are then allocated to the host instruments themselves, usually resulting in those instruments being recorded at a discount
from their face value. The discount from the face value of the convertible debt, together with the stated interest on the instrument,
is amortized over the life of the instrument through periodic charges to interest expense.
Net Loss Per Common Share
Basic net loss per common share is computed
by dividing net loss by the weighted-average number of common shares outstanding during the period. Potential common stock equivalents
are determined using the treasury stock method. For diluted net loss per share purposes, the Company excludes stock options and other
stock-based awards, including shares issued as a result of option exercises that are subject to repurchase by the Company, whose effect
would be anti-dilutive from the calculation. During the year ended December 31, 2021 and 2020, common stock equivalents were excluded
from the calculation of diluted net loss per common share, as their effect was anti-dilutive due to the net loss incurred. Therefore,
basic and diluted net loss per share was the same in all periods presented.
The Company had 154,518,887 and 28,443,298 potentially
dilutive options and convertible securities that have been excluded from the computation of diluted weighted-average shares outstanding
as of December 31, 2021, and 223,237,026 and 26,694,516 potentially dilutive options and convertible securities that have been excluded
from the computation of diluted weighted-average shares outstanding as of December 31, 2020, as they would be anti-dilutive.
Treasury Stock
The Company accounts for treasury stock under the
cost method and includes treasury stock as a component of stockholder’s deficit.
Fair Value of Financial Instruments
The guidance for fair value measurements, ASC 820,
Fair Value Measurements and Disclosures, establishes the authoritative definition of fair value, sets out a framework for measuring fair
value, and outlines the required disclosures regarding fair value measurements. Fair value is the price that would be received to sell
an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an
orderly transaction between market participants at the measurement date. The Company uses a three-tier fair value hierarchy based upon
observable and non-observable inputs as follow:
|
• |
Level 1 – Quoted market prices in active markets for identical assets and liabilities; |
|
• |
Level 2 – Inputs, other than level 1 inputs, either directly or indirectly observable; and |
|
• |
Level 3 – Unobservable inputs developed using internal estimates and assumptions (there is little or no market date) which reflect those that market participants would use. |
|
The Company records its derivative activities at fair
value. As of December 31, 2021, no derivative liabilities are recorded.
Off Balance Sheet Arrangements
The Company does not have any off-balance sheet arrangements.
Uncertain Tax Positions
The Company did not take any uncertain tax positions
and had no adjustments to unrecognized income tax liabilities or benefits pursuant to the provisions of Section 740-10-25 for the year
ended December 31, 2021.
Income
Taxes
The Company accounts for income taxes under Section
740-10-30 of the FASB Accounting Standards Codification. Deferred income tax assets and liabilities are determined based upon differences
between the financial reporting and tax basis of assets and liabilities and are measured using the enacted tax rates and laws that will
be in effect when the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management
concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted
tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.
The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the consolidated statements of operations
in the period that includes the enactment date.
Recent Accounting Pronouncements
The Company has reviewed all recently issued, but
not yet effective, accounting pronouncements, and does not believe the future adoption of any such pronouncements may be expected to cause
a material impact on its financial condition or the results of its operations.
The Company accounts for stock-based compensation
for employees and directors in accordance with Accounting Standards Codification 718, Compensation (“ASC 718”) as issued by
the FASB. ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the
statement of operations based on their fair values. Under the provisions of ASC 718, stock-based compensation costs are measured at the
grant date, based on the fair value of the award, and are recognized as an expense over the employee’s requisite service period
(generally the vesting period of the equity grant). The fair value of the Company’s common stock options are estimated using the
Black Scholes option-pricing model with the following assumptions: expected volatility, dividend rate, risk free interest rate and the
expected life. The Company expenses stock-based compensation by using the straight-line method. In accordance with ASC 718 and, excess
tax benefits realized from the exercise of stock-based awards are classified as cash flows from operating activities. All excess tax benefits
and tax deficiencies (including tax benefits of dividends on share-based payment awards) are recognized as income tax expense or benefit
in the condensed consolidated statements of operations. The Company accounts for stock-based compensation awards issued to non-employees
for services, as prescribed by ASC 718-10, at either the fair value of the services rendered or the instruments issued in exchange for
such services, whichever is more readily determinable, using the measurement date guidelines enumerated in Accounting Standards Update
(“ASU”) 2018-07.
In February 2016, the FASB issued ASU 2016-02, “Leases”
Topic 842, which amends the guidance in former ASC Topic 840, Leases. The new standard increases transparency and comparability
most significantly by requiring the recognition by lessees of right-of-use assets and lease liabilities on the balance sheet for all leases
longer than 12 months. Under the standard, disclosures are required to meet the objective of enabling users of financial statements to
assess the amount, timing, and uncertainty of cash flows arising from leases. For lessees, leases will be classified as finance or
operating, with classification affecting the pattern and classification of expense recognition in the income statement. The Company adopted
the new lease guidance effective January 1, 2019. The Company is not a party to any leases and therefore is not showing any asset
or liability related to leases in the current period or prior periods.
ASC 740 prescribes a comprehensive model for how companies
should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on
a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the
position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as
the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority
assuming full knowledge of the position and relevant facts.
Subsequent Events
On January 20, 2022 the Company entered into a
purchase agreement with the former CEO of Real Brands Inc. Jerome Pearring. The Company sold certain intellectual property rights
and Real Brands Venture Group a wholly owned subsidiary with the assumption of certain liabilities related to the IP. The purchase
price is the assignment of 1,000,000 shares of series A preferred stock and waiver of any possible severance payments.
General
The Company’s primary business is hemp CBD
oil/isolate extraction, wholesaling of CBD oils and isolate, and production and sales of hemp-derived CBD consumer brands. The Company’s
brand development strategy will be to leverage existing Company resources into creating online sales, licensing opportunities and a distribution
network for proprietary legal hemp.
Components of Statements of Operations
Revenue
Product revenue consists of sales of CBD oils, tinctures
and creams under our own brand name and white labeled along with wholesale sale of isolate and distillate oils net of returns, discounts
and allowances. Once a purchase order is received, the order is packaged and shipped to the customer. Depending on the customer, some
orders are paid at the time of purchase and others have 30 day terms. We recognize the revenue when the order is delivered and received
by the customer.
Cost of Goods Sold
Cost of goods sold represents costs of raw material,
packaging, printing and labels, prepackaged goods for sale and the write down of any non-moving components of inventory.
We expect our cost of goods sold per unit
to decrease as we scale our operations, improve product designs and work with our third-party suppliers to lower costs.
Operating Expenses
General and Administrative. Our general and
administrative expenses consist primarily of compensation, benefits, travel and other costs for employees. In addition, general and administrative
expenses include third-party consulting, accounting services, repairs and maintenance, utilities for our building and information technology.
We expect general and administrative expenses to increase as we grow our business and add additional employees.
Professional Fees
Professional fees consist of legal fees and audit
fees.
Interest Expense
Interest expense consists primarily of interest from
notes due to debtholders and interest on the mortgage.
Liquidity and Capital Resources
We have had limited operations during 2021 due
to renovations being conducted to our building and hemp processing facility at 12 Humbert St., in North Providence, RI. We were able
to issue equity to finance the renovations and purchase additional equipment. We continue to pursue additional sources
of capital though we have no current arrangements with respect to, or sources of, additional financing at this time and there can be
no assurance that any such financing will become available. We will need to raise additional capital in order to execute on our
business plan. We intend on raising additional capital in the short term by selling equity through private placements.
RESULTS OF OPERATIONS
Year ended December 31, 2021 compared to year ended
December 31, 2020
Revenue was $5,546 for the year ended December
31, 2021 and $24,582 for the year ended December 31, 2020. The Company spent 2021 renovating the new facility in North
Providence RI and did not concentrate on generating revenue during the year. We still need to raise a sufficient amount of capital to
provide the resources required that would enable us to execute our business plan.
Cost of goods sold increased by $240,080 from $22,540 for the year ended
December 31, 2020 to $262,620 for the year ended December 31, 2021. The increase is attributable the Company writing off the value of
the inventory due to lack of movement of the inventory for over one year and due to the pandemic and renovations on the new facility.
General and administrative (G &
A) expenses increased by $211,983 from $259,511 to $471,494 for the year ended December 31, 2021. The increase is
due to an increase in activity around the renovation and build out of the new facility and the raising of funds in order to
facilitate that process, which once completed will not be ongoing.
Professional fees expenses decreased
by $154,970 from $349,525 to $194,556 for the year ended December 31, 2021. The decrease is due to additional professional
fees related to the merger and the requirement for two audits in the prior year, one for each of the merged Companies.
Payroll and related expenses decreased by $23,007
to $326,424 from $349,431 for the year ended December 31, 2021. The decrease is due to a reduction in hours for the production related
employees because of the renovations being done to the building.
For the year ended December 31, 2021, the Company
recorded an option expense of $1,065,390, representing the amortization of the value of the options issued in 2020 that have not yet vested.
For the year ended December 31, 2020, the Company
recorded an option expense of $3,825,479, representing the amortization of the value of the options issued in 2020 and 2019 that have
not yet vested.
For the year ended December 31, 2021, the Company
had a forgiveness of PPP debt of $143,485.
For the year ended December 31, 2021, the Company
had interest expense of $33,040. For the year ended December 31, 2020, the Company had interest expense of $31,183.
For the year ended December 31, 2021, the
Company recorded a loss on disposal of a assets of $385,989. The Company wrote down the value of the equipment due to there being no
use of the equipment for an extended period of time related to the pandemic and renovations to the new facility.
For the year ended December 31, 2021, the Company
had a warrant expense of $37,753 for warrants issued to extend the term of the convertible debt.
As a result of the foregoing, we had a net loss of $2,795,771 for the year ended December 31, 2021
compared to a net loss of $6,272,910 for the year ended December 31, 2020.
Liquidity and Capital Resources
As of December 31, 2021, the Company had cash
and cash equivalents of a $197,255 as compared to $247,892 as of December 31, 2020, representing a decrease of $50,637. As of
December 31, 2021, the Company had a working capital deficit of $1,103,739 as compared to a working capital deficit of $636,179 as
of December 31, 2020, representing an increase in the deficit of $467,560.
The Company is seeking additional capital in the private
and/or public equity markets to continue operations and build sales, marketing, brand and distribution. The Company is currently evaluating
additional equity and debt financing opportunities and may execute them when appropriate. However, there can be no assurances that the
Company can consummate such a transaction or consummate a transaction at favorable prices.
Company
plans on increased sales of its products in the market. However, there can be no assurances that the sales will increase or that even if
they do increase that it will increase sufficiently to generate the necessary cash.
ITEM 8. FINANCIAL
STATEMENTS.
REPORT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM
To the Board of Directors and Stockholders of
Real Brands, Inc.
and Its Subsidiaries:
Opinion on the
Financial Statements
We have audited the
accompanying balance sheets of Real Brands, Inc. and its subsidiaries (“the Company”) as of December 31, 2021 and December
31, 2020 and the related statements of operations, stockholders’ deficit, cash flows and the related notes to consolidated financial
statements (collectively referred to as the consolidated financial statements) for the years ended December 31, 2021 and December 31,
2020. In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company
at December 31, 2021 and December 31, 2020, and the results of its operations and its cash flows for the year then ended, in conformity
with accounting principles generally accepted in the United States of America.
Basis for Opinion
These consolidated financial statements are the responsibility
of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements
based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB)
and American Institute of Certified Public Accountants (AICPA) and are required to be independent with respect to the Company in accordance
with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards
of the PCAOB and Generally Accepted Audit Standards (GAAS). Those standards require that we plan and perform the audit to obtain reasonable
assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not
required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we
are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion
on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audit included
performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing
procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures
in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management,
as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for
our opinion.
The Company’s Ability to Continue as a Going Concern
The accompanying consolidated financial statements
have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements,
the Company has an accumulated deficit, recurring losses, and expects continuing future losses, These factors raise substantial doubt
about the Company’s ability to continue as a going concern. Management’s evaluation of the events and conditions and management’s
plans regarding these matters are also described in Note 1. The consolidated financial statements do not include any adjustments that
might result from the outcome of this uncertainty.
Critical Audit Matters
The critical audit matters communicated below are
matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the
audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially
challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the
financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions
on the critical audit matters or on the accounts or disclosures to which they relate.
Long-lived asset valuation
As discussed in Note 6 to the consolidated financial
statements, the Company utilizes projections of future cash flows to determine if there are indications of impairment of long-lived assets,
specifically, land, buildings and equipment which totaled over $2 million as of December 31, 2021.
The Company tests for impairment whenever events or
changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. Such indicators may include, among
others: a significant decline in future cash flows and changes in expected useful life which relates to the Company’s ability and
intent to hold its asset groups for a period of time that recovers their carrying value.
We identified the valuation of certain long-lived
assets to be a critical audit matter. The valuation is based upon undiscounted future cash flows related to certain long-lived assets,
specifically, land, buildings, and equipment. Whereas auditor judgments were required to evaluate subjective assumptions in the Company’s
analysis of undiscounted cash flows. These included estimated future revenue and operating expenses. Adverse changes in the assumptions
could have a significant impact on whether an indicator of impairment has been identified and could have a material impact on the Company’s
consolidated financial statements.
The following are the primary procedures we performed
to address this critical audit matter:
| · | We obtained an understanding
for the Company’s process for determining indicators of impairment of long-lived assets and the Company’s evaluation of impairment
when indicators arose. |
| · | We visited the site of the long-lived
assets located that were considered high risk for potential impairment. |
| · | We evaluated the reasonableness
of the Company’s forecasted revenues, operating results and cash flows by performing an independent sensitivity analysis related
to the key inputs to forecasted cash flows. |
The firm has served this client since December 2018.
/s/ L&L CPAS, PA
L&L CPAS, PA
Certified Public Accountants
Plantation, FL
The United States of America
April 6, 2022
| |
| |
|
Real Brands, Inc. and Subsidiaries |
Consolidated Balance Sheets |
December 31, 2021 and 2020 |
Audited |
|
| |
2021 | |
2020 |
| |
| |
|
ASSETS | |
| | | |
| | |
CURRENT ASSETS: | |
| | | |
| | |
Cash and cash equivalents | |
$ | 197,255 | | |
$ | 247,892 | |
Accounts receivables | |
| 898 | | |
| 175 | |
Inventory | |
| — | | |
| 230,951 | |
Total current assets | |
| 198,153 | | |
| 479,018 | |
| |
| | | |
| | |
Deposits | |
| 530 | | |
| 530 | |
Property and equipment - net of depreciation | |
| 1,239,809 | | |
| 1,645,336 | |
TOTAL ASSETS | |
$ | 1,438,492 | | |
$ | 2,124,884 | |
| |
| | | |
| | |
LIABILITIES AND STOCKHOLDERS’ DEFICIT | |
| | | |
| | |
| |
| | | |
| | |
CURRENT LIABILITIES: | |
| | | |
| | |
Accounts payable and accrued expenses | |
$ | 513,065 | | |
$ | 637,100 | |
Accrued expenses related party | |
| 402,347 | | |
| 91,618 | |
Loan payable related party | |
| 133,605 | | |
| 133,605 | |
Convertible note payable related party | |
| 200,000 | | |
| 200,000 | |
Notes payable | |
| 7,250 | | |
| 7,250 | |
Contingent liabilities | |
| 45,625 | | |
| 45,625 | |
TOTAL CURRENT LIABILITIES | |
| 1,301,892 | | |
| 1,115,197 | |
| |
| | | |
| | |
LONG TERM LIABILITIES | |
| | | |
| | |
PPP Loan | |
| — | | |
| 143,485 | |
Mortgage payable | |
| 148,551 | | |
| 170,526 | |
Total Long Term Liabilities | |
| 148,551 | | |
| 314,011 | |
| |
| | | |
| | |
TOTAL LIABILITIES | |
| 1,450,443 | | |
| 1,429,208 | |
| |
| | | |
| | |
STOCKHOLDERS’ EQUITY | |
| | | |
| | |
Series A Preferred stock, $.001 par value; 2,000,000 shares authorized, 1,000,000 issued and outstanding as of December 31, 2021 and 2020, respectively. | |
| 1,000 | | |
| 1,000 | |
Common stock, $.001 par value; 3,998,000,000 shares authorized as of December 31, 2021 and 2020; 2,677,529,115 shares issued and outstanding as of December 31, 2021, and 2,358,780,396 shares issued and outstanding as of December 31, 2020. | |
| 2,677,529 | | |
| 2,358,780 | |
Common stock subscribed, 3,694,900 and 194,263,483 shares at December 31, 2021 and December 31, 2020, respectively. | |
| 96,403 | | |
| 414,679 | |
Additional paid-in capital | |
| 8,881,728 | | |
| 6,794,057 | |
Accumulated deficit | |
| (11,668,611 | ) | |
| (8,872,840 | ) |
| |
| | | |
| | |
TOTAL
STOCKHOLDERS’ EQUITY (DEFICIT) | |
| (11,951 | ) | |
| 695,676 | |
| |
| | | |
| | |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | |
$ | 1,438,492 | | |
$ | 2,124,884 | |
| |
| | | |
| | |
See the accompanying notes to these audited consolidated financial statements. |
| |
| |
|
REAL BRANDS, INC. AND SUBSIDIARIES |
CONSOLIDATED STATEMENTS OF OPERATIONS |
FOR THE YEARS ENDED DECEMBER 31, 2021 and 2020 |
AUDITED |
| |
| |
|
| |
2021 | |
2020 |
REVENUE: | |
| |
|
Revenues | |
$ | 5,546 | | |
$ | 24,582 | |
Total revenue | |
| 5,546 | | |
| 24,582 | |
Cost of goods sold | |
| 262,620 | | |
| 22,540 | |
Gross (loss) profit | |
| (257,074 | ) | |
| 2,042 | |
| |
| | | |
| | |
OPERATING EXPENSES: | |
| | | |
| | |
| |
| | | |
| | |
General and administrative | |
| 471,494 | | |
| 259,511 | |
Professional fees | |
| 194,556 | | |
| 349,525 | |
Stock compensation | |
| — | | |
| 1,339,530 | |
Payroll and related | |
| 326,424 | | |
| 349,431 | |
Stock option expense | |
| 1,065,390 | | |
| 3,825,479 | |
Total operating expenses | |
| 2,057,864 | | |
| 6,123,476 | |
| |
| | | |
| | |
Operating loss | |
| (2,314,938 | ) | |
| (6,121,434 | ) |
| |
| | | |
| | |
OTHER INCOME (EXPENSES): | |
| | | |
| | |
Forgiveness of PPP debt | |
| 143,485 | | |
| — | |
Depreciation expense | |
| (167,536 | ) | |
| (120,293 | ) |
Impairment of assets | |
| (385,989 | ) | |
| — | |
Warrant expense | |
| (37,753 | ) | |
| — | |
Interest expense | |
| (33,040 | ) | |
| (31,183 | ) |
Total other (expenses) income | |
| (480,833 | ) | |
| (151,476 | ) |
| |
| | | |
| | |
LOSS FROM OPERATIONS | |
| (2,795,771 | ) | |
| (6,272,910 | ) |
| |
| | | |
| | |
PROVISION FOR INCOME TAXES | |
| — | | |
| — | |
| |
| | | |
| | |
NET LOSS | |
$ | (2,795,771 | ) | |
$ | (6,272,910 | ) |
| |
| | | |
| | |
BASIC AND DILUTED NET LOSS PER SHARE
ATTRIBUTABLE TO COMMON STOCKHOLDERS | |
$ | —** | | |
$ | (0.03 | ) |
| |
| | | |
| | |
WEIGHTED AVERAGE SHARES OUTSTANDING | |
| 2,624,071,816 | | |
| 216,636,166 | |
| |
| | | |
| | |
** |
less than $0.01 per share | |
| | | |
| | |
| |
| | | |
| | |
See the accompanying notes to these audited consolidated financial statements. |
| |
| |
| |
| |
| |
| |
| |
| |
|
REAL BRANDS, INC. AND SUBSIDIARIES |
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) |
FOR THE YEAR ENDED DECEMBER 31, 2020 AND THE YEAR ENDED DECEMBER 31, 2021 |
| |
| |
| |
| |
| |
| |
| |
| |
|
| |
Preferred Stock | |
| |
| |
Common | |
Additional | |
| |
|
| |
Series A | |
Common Stock | |
Stock | |
Paid-in | |
Accumulated | |
|
| |
Shares | |
Amount | |
Shares | |
Amount | |
Subscribed | |
Capital | |
Deficit | |
TOTAL |
| |
| |
| |
| |
| |
| |
| |
| |
|
Balance December 31, 2019 | |
| — | | |
| — | | |
| 2,127,190,401 | | |
| 2,127,190 | | |
| 164,679 | | |
| 859,434 | | |
| (2,599,930 | ) | |
| 551,373 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Recapitalization | |
| 1,000,000 | | |
| 1,000 | | |
| 164,671,867 | | |
| 164,672 | | |
| 623,728 | | |
| (1,852,079 | ) | |
| — | | |
| (1,062,679 | ) |
Recapitalization - debt settlement prior to reorganization | |
| | | |
| | | |
| 17,318,128 | | |
| 17,318 | | |
| (251,113 | ) | |
| 233,795 | | |
| — | | |
| — | |
Recapitalization - conversion prior to reorganization | |
| — | | |
| — | | |
| 10,000,000 | | |
| 10,000 | | |
| (62,615 | ) | |
| 52,615 | | |
| — | | |
| — | |
Contributions | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 5,700,807 | | |
| — | | |
| 5,700,807 | |
Issuance for cash | |
| — | | |
| — | | |
| 26,000,000 | | |
| 26,000 | | |
| (60,000 | ) | |
| 234,000 | | |
| — | | |
| 200,000 | |
Issuance for subscriptions payable | |
| — | | |
| — | | |
| 13,600,000 | | |
| 13,600 | | |
| — | | |
| 781,200 | | |
| — | | |
| 794,800 | |
Option granted | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 784,286 | | |
| — | | |
| 784,286 | |
Net loss for the period ended December 31, 2020 | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (6,272,910 | ) | |
| (6,272,910 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Balance December 31, 2020 | |
| 1,000,000 | | |
| 1,000 | | |
| 2,358,780,396 | | |
| 2,358,780 | | |
| 414,679 | | |
| 6,794,057 | | |
| (8,872,840 | ) | |
| 695,676 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Issuance for reverse merger | |
| — | | |
| — | | |
| 164,680,119 | | |
| 164,680 | | |
| (164,680 | ) | |
| — | | |
| — | | |
| — | |
Issuance of common stock for cash | |
| — | | |
| — | | |
| 98,974,969 | | |
| 98,975 | | |
| (153,595 | ) | |
| 1,039,621 | | |
| — | | |
| 985,001 | |
Cashless exercise of stock options | |
| — | | |
| — | | |
| 55,093,631 | | |
| 55,094 | | |
| — | | |
| (55,094 | ) | |
| — | | |
| — | |
Stock options granted pursuant to the agreements | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 1,065,390 | | |
| — | | |
| 1,065,390 | |
Warrant expense | |
| | | |
| | | |
| | | |
| | | |
| | | |
| 37,753 | | |
| | | |
| 37,753 | |
Net loss for the year ended December 31, 2021 | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| (2,795,771 | ) | |
| (2,795,771 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Balance December 31, 2021 | |
| 1,000,000 | | |
| 1,000 | | |
| 2,677,529,115 | | |
| 2,677,529 | | |
| 96,403 | | |
| 8,881,728 | | |
| (11,668,611 | ) | |
| (11,951 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
See the accompanying notes to these audited consolidated financial statements. |
|
|
|
|
|
|
|
|
|
REAL BRANDS, INC. AND SUBSIDIARIES |
CONSOLIDATED STATEMENTS OF CASH FLOWS |
FOR THE YEARS ENDED DECEMBER 31, 2021 and 2020 |
AUDITED |
|
| |
2021 | |
2020 |
CASH FLOWS FROM OPERATING ACTIVITIES: | |
| |
|
Net loss | |
$ | (2,795,771 | ) | |
$ | (6,272,910 | ) |
Adjustments to reconcile net loss to net cash used in operating activities: | |
| | | |
| | |
Gain on forgiveness of PPP loan | |
| (143,485 | ) | |
| — | |
Option expense | |
| 1,065,390 | | |
| 3,825,479 | |
Warrant expense | |
| 37,753 | | |
| — | |
Stock based compensation | |
| — | | |
| 1,339,530 | |
Depreciation expense | |
| 167,536 | | |
| 120,293 | |
Changes in operating assets and liabilities: | |
| | | |
| | |
Accounts receivable | |
| (721 | ) | |
| (175 | ) |
Inventory | |
| 230,951 | | |
| — | |
Impairment of assets | |
| 385,989 | | |
| — | |
Deposit | |
| — | | |
| 4,000 | |
Prepaid expenses | |
| — | | |
| 38,000 | |
Accounts payable and accrued expenses | |
| 186,696 | | |
| 320,935 | |
Contingency liabilities | |
| — | | |
| 45,625 | |
Net cash used in operating activities | |
| (865,664 | ) | |
| (579,223 | ) |
| |
| | | |
| | |
CASH FLOWS FROM INVESTING ACTIVITIES: | |
| | | |
| | |
Purchase of property and equipment | |
| (147,999 | ) | |
| (509,412 | ) |
Net cash (used in) investing activities | |
| (147,999 | ) | |
| (509,412 | ) |
| |
| | | |
| | |
CASH FLOWS FROM FINANCING ACTIVITIES: | |
| | | |
| | |
Proceeds from promissory notes | |
| — | | |
| 7,250 | |
Proceeds from loans payable | |
| — | | |
| 133,605 | |
Repayment of mortgage payable | |
| (21,975 | ) | |
| (19,390 | ) |
Proceeds from PPP loan | |
| — | | |
| 143,485 | |
Proceeds from sale of common stock | |
| 985,001 | | |
| 980,000 | |
Net cash provided by financing activities | |
$ | 963,026 | | |
$ | 1,244,950 | |
| |
| | | |
| | |
NET CHANGE IN CASH AND CASH EQUIVALENTS | |
$ | (50,637 | ) | |
$ | 156,315 | |
| |
| | | |
| | |
CASH AND CASH EQUIVALENTS, beginning of year | |
$ | 247,892 | | |
$ | 91,579 | |
| |
| | | |
| | |
CASH AND CASH EQUIVALENTS, end of year | |
$ | 197,255 | | |
$ | 247,892 | |
| |
| | | |
| | |
SUPPLEMENTAL CASH FLOW INFORMATION: | |
| | | |
| | |
Cash paid for interest | |
$ | 8,686 | | |
$ | 9,588 | |
Cash paid for income taxes | |
$ | — | | |
$ | — | |
| |
| | | |
| | |
NONCASH INVESTING AND FINANCING ACTIVITIES: | |
| | | |
| | |
Recapitalization | |
$ | — | | |
$ | (1,062,679 | ) |
Shares for subscription payable prior to recapitalization | |
$ | — | | |
$ | 794,800 | |
Shares for settlement prior to recapitalization | |
$ | — | | |
$ | 186,663 | |
| |
| | | |
| | |
| |
| | | |
| | |
See the accompanying notes to these audited consolidated financial statements. |
REAL BRANDS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2021 AND 2020
NOTE 1. ORGANIZATION, BACKGROUND, AND BASIS OF PRESENTATION
Real Brands, Inc. (“Real Brands” or the
“Company”), was incorporated under the laws of the state of Nevada on November 6, 1992. The Company was formed under the name
Mercury Software. From 1997 to 2005 the Company changed its name several times. On October 10, 2005, the Company changed its name to Global
Beverage Solutions, Inc. and began trading on the OTC Bulletin Board under the symbol GBVS.OB.
On October 22, 2013, the Company changed its name
to Real Brands, Inc. The Financial Industry Regulatory Authority (“FINRA”) approved Real Brands’ corporate actions regarding
its name change and its new stock symbol request and approved Real Brands’ 150:1 Reverse Stock Split. The new symbol was designated
as GBVSD. On November 19, 2013, the ticker symbol changed to RLBD.
On October 22, 2020, the majority of the shareholders
of the Company, by written consent, agreed to a “reverse triangular” merger with CASH Acquisition Corp., a Delaware corporation
and wholly-owned subsidiary of the Company formed for the purpose of the merger, and Canadian American Standard Hemp Inc., a Delaware
corporation (“CASH”), whereby the Company acquired all of the outstanding shares of CASH and merged it with and into CASH
Acquisition Corp. Real Brands’ name and trading symbol were maintained, with CASH shareholders acquiring majority control of Real
Brands.
The merger
was accounted for as a reverse merger, whereby CASH was considered the accounting acquirer and became our wholly-owned subsidiary. In
accordance with the accounting treatment for a “reverse merger”, the Company’s historical financial statements prior
to the reverse merger has been replaced with the historical financial statements of CASH prior to the reverse merger. The consolidated
financial statements after completion of the reverse merger include the assets, liabilities, and results of operations of the combined
company from and after the closing date of the reverse merger, with only certain aspects of pre-consummation stockholders’ equity
remaining in the consolidated financial statements.
Going concern
The ability of the Company to obtain necessary financing
to build its sales, brand, marketing and distribution and fund ongoing operating expenses is uncertain. The ability of the Company to
generate sales revenue to offset the expenses and obtain profitability is uncertain. The Company had a net loss as of December 31, 2021
and 2020, of $2,795,771 and $6,272,910, respectively. These material uncertainties cast doubt on the Company’s ability to continue
as a going concern. In the event the Company’s revenues do not significantly increase, the Company will require additional financing
from time to time, which it intends to obtain through the issuance of common shares, debt, bonds, grants and other financial instruments.
While the Company has been successful in raising funds through the issuance of common shares and obtaining debt in the past, there is
no assurance that it will be able to obtain adequate financing in the future or that such financing will be available on acceptable terms
and while the Company believes that its revenues will increase it does not currently expect them to generate sufficient cash in the immediate
future.
Liquidity
As of December 31, 2021, the Company had cash
and cash equivalents of a $197,255 as compared to $247,892 as of December 31, 2020, representing a decrease of $50,637. As of December
31, 2021, the Company had a working capital deficit of $1,103,739 as compared to a working capital deficit of $636,179 as of December
31, 2020, representing an increase in the deficit of $467,560.
Plans with respect to its liquidity management include
the following:
|
• |
The Company is seeking additional capital in the private and/or public equity markets to continue operations and build sales, marketing, brand and distribution. The Company is currently evaluating additional equity and debt financing opportunities and may execute them when appropriate. However, there can be no assurances that the Company can consummate such a transaction or consummate a transaction at favorable pricing. |
|
• |
The Company plans on increased sales of its products in the market. However, there can be no assurances that the sales will increase or that even if they do increase that it will increase sufficiently to generate the necessary cash. |
NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation and Principles of Consolidation
The Company’s consolidated financial statements
and the notes thereto have been prepared in accordance with Generally Accepted Accounting Principles (“GAAP”) in the United
States of America. The consolidated financial statements include Real Brands, and its wholly owned subsidiaries. One subsidiary, Real
Brands Venture Group, LLC, has been inactive for the last two years and only maintains a debt instrument on its financial records. DePetrillo
Real Estate Holdings, LLC is a wholly owned subsidiary of CASH Acquisition Corp. and the owner of the Company’s building in Rhode
Island. American Standard Hemp Inc. is a wholly owned subsidiary of CASH Acquisition Corp. and holds the hemp licenses in Rhode Island.
All significant intercompany accounts and transactions have been eliminated.
Use of estimates and judgments
The preparation of financial statements in conformity
with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during
the reporting period. Key areas of estimation include the estimated useful lives of property, plant, equipment and intangibles assets
and liabilities, income taxes, and the valuation of stock-based compensation. Due to the uncertainty inherent in such estimates, actual
results may differ from the Company’s estimates.
Accounting standard updates
From time to time, new accounting pronouncements are
issued by the Financial Accounting Standards Board (“FASB”) or other standard setting bodies that are adopted by the Company
as of the specified effective date. Unless otherwise discussed, the Company believes that the effect of recently issued standards that
are not yet effective will not have a material effect on its consolidated financial position or results of operations upon adoption.
Segment Reporting
The Company operates as one segment, in which
management uses one measure of profitability, and all of the Company’s assets are located in the United States of America. The
Company does not operate separate lines of business or separate business entities with respect to any of its product candidates. Accordingly,
the Company does not have separately reportable segments.
Cash and Cash Equivalents
The Company considers all highly liquid investments
with an original maturity of three months or less when purchased to be a cash equivalent.
Accounts Receivable and Allowance for Doubtful
Accounts
The Company performs periodic credit evaluations of
its customers’ financial conditions and generally does not require collateral. The Company reviews all outstanding accounts receivable
for collectability on a quarterly basis. An allowance for doubtful accounts is recorded for any amounts deemed uncollectable. The Company
does not accrue interest receivable on past due accounts receivable.
Concentrations of Credit Risk
The Company, from time to time during the years covered
by these consolidated financial statements, may have bank balances in excess of its insured limits. Management has deemed this a normal
business risk.
Inventory
Inventory is comprised of raw hemp and hemp oil in
different phases of production to completion of final product. Products include tinctures, creams and lotions. Inventory is valued at
cost. No packaging material of any kind is included in inventory. Packaging materials are expensed as incurred.
Property and Equipment
On February 15, 2020 the Company
purchased DePetrillo Real Estate Holdings, LLC, a Rhode Island Limited Liability Company having as it’s only asset the
building at 12 Humbert Street in North Providence Rhode Island. The building is the Company’s headquarters and a hemp
processing facility. The purchase price of the building was 2 million shares of CASH common stock, $25,000 in cash and the
assumption of the mortgage which at the time was $189,916. The prior owner agreed to put the $25,000 payment into building
improvements. The building and land were appraised at $475,000. The building is being depreciated over 15 years on a straight-line
basis starting October 1, 2021, the date building improvements were completed. Depreciation expense on the building for the year ended
December 31, 2021 was $7,917.
The
Company made $121,411 in building improvements and purchases of $26,588 in
furniture and equipment during the year ended December 31, 2021. The Company made $644,412 in building improvements during the year ended
December 31, 2020. $135,000 of those improvements were in the form of CASH common stock valued at $0.50 per share. Building improvements
is being depreciated over 15 years commencing from the completion of the work, October 1, 2021. Depreciation expense on building improvements
for the year ended December 31, 2021 was $13,097.
Property and equipment are recorded at
cost. Depreciation is computed using the straight-line method over estimated useful lives of five years. On December 31, 2021 the
Company wrote down the value of the equipment to $0 because the equipment had been sitting idle for over a year resulting in a loss
on disposal of assets of $385,989. The furniture and equipment and related accumulated depreciation were removed from the books as
of December 31, 2021. Depreciation expense on the property and equipment for the year ended December 31, 2021, before it was written
off was $146,522. Total depreciation expense for the year ended December 31, 2021 was $167,536. Expenditures for repairs and
maintenance are expensed as incurred.
Impairment of Long-Lived Assets
The Company reviews long-lived assets, including property and equipment, for impairment
whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. Factors
that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation
to expectations, significant negative industry or economic trends, and significant changes or planned changes in the use of the assets.
If an impairment review is performed to evaluate long-lived asset for recoverability, the Company compares forecasts of undiscounted cash
flows expected to result from the use and eventual disposition of the long-lived asset to its carrying value. An impairment loss would
be recognized when estimated undiscounted future cash flows expected to result from the use of an asset over its fair value, determined
based on discounted cash flows is less than the carrying value on the books of the Company.
Revenue Recognition
The Company follows, ASC 606 Revenue from
Contracts with Customers which establishes a single and comprehensive framework and sets out how much revenue is to be recognized,
and when. The core principle is that a vendor should recognize revenue to depict the transfer of promised goods or services to
customers in an amount that reflects the consideration to which the vendor expects to be entitled in exchange for those goods or
services. Revenue will now be recognized by a vendor when control over the goods or services is transferred to the customer. In
contrast, Revenue based revenue recognition is around an analysis of the transfer of risks and rewards; this now forms one of a
number of criteria that are assessed in determining whether control has been transferred. The application of the core principle in
ASC 606 is carried out in five steps: Step 1 – Identify the contract with a customer: a contract is defined as an agreement
(including oral and implied), between two or more parties, that creates enforceable rights and obligations and sets out the criteria
for each of those rights and obligations. The contract needs to have commercial substance and it is probable that the entity will
collect the consideration to which it will be entitled. Step 2 – Identify the performance obligations in the contract: a
performance obligation in a contract is a promise (including implicit) to transfer a good or service to the customer. Each
performance obligation should be capable of being distinct and is separately identifiable in the contract. Step 3 – Determine
the transaction price: transaction price is the amount of consideration that the entity can be entitled to, in exchange for
transferring the promised goods and services to a customer, excluding amounts collected on behalf of third parties. Step 4 –
Allocate the transaction price to the performance obligations in the contract: for a contract that has more than one performance
obligation, the entity will allocate the transaction price to each performance obligation separately, in exchange for satisfying
each performance obligation. The acceptable methods of allocating the transaction price include adjusted market assessment approach,
expected cost plus a margin approach, and the residual approach in limited circumstances. Discounts given should be allocated
proportionately to all performance obligations unless certain criteria are met and reallocation of changes in standalone selling
prices after inception is not permitted. Step 5 – Recognize revenue as and when the entity satisfies a performance obligation:
the entity should recognize revenue at a point in time, except if it meets any of the three criteria, which will require recognition
of revenue over time: the entity’s performance creates or enhances an asset controlled by the customer, the customer
simultaneously receives and consumes the benefit of the entity’s performance as the entity performs, and the entity does not
create an asset that has an alternative use to the entity and the entity has the right to be paid for performance to date.
Stock-based Compensation
The Company expenses stock-based compensation to employees
and consultants based on the fair value at grant date, which generally is the agreement date the Company entered into with employees or
consultants. To date the Company has issued restricted common stock shares and preferred stock.
Beneficial Conversion Features of Convertible Securities
Conversion options that are not bifurcated as a derivative
pursuant to ASC 815 and not accounted for as a separate equity component under the cash conversion guidance are evaluated to determine
whether they are beneficial to the investor at inception (a beneficial conversion feature) or may become beneficial in the future due
to potential adjustments. The beneficial conversion feature guidance in ASC 470-20 applies to convertible stock as well as convertible
debt which are outside the scope of ASC 815. A beneficial conversion feature is defined as a nondetachable conversion feature that is
in the money at the commitment date. The beneficial conversion feature guidance requires recognition of the conversion option’s
in-the-money portion, the intrinsic value of the option, in equity, with an offsetting reduction to the carrying amount of the instrument.
The resulting discount is amortized as a dividend over either the life of the instrument, if a stated maturity date exists, or to the
earliest conversion date, if there is no stated maturity date. If the earliest conversion date is immediately upon issuance, the dividend
must be recognized at inception. When there is a subsequent change to the conversion ratio based on a future occurrence, the new conversion
price may trigger the recognition of an additional beneficial conversion feature on occurrence.
Derivatives
The Company reviews the terms of convertible debt
issued to determine whether there are embedded derivative instruments, including embedded conversion options, which are required to be
bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more
than one embedded derivative instrument, including the conversion option, that is required to be bifurcated, the bifurcated derivative
instruments are accounted for as a single, compound derivative instrument.
Bifurcated embedded derivatives are initially
recorded at fair value and are then revalued at each reporting date with changes in the fair value reported as non-operating income or
expense. When the equity or convertible debt instruments contain embedded derivative instruments that are to be bifurcated and accounted
for as liabilities, the total proceeds received are first allocated to the fair value of all the bifurcated derivative instruments. The
remaining proceeds, if any, are then allocated to the host instruments themselves, usually resulting in those instruments being recorded
at a discount from their face value. The discount from the face value of the convertible debt, together with the stated interest on the
instrument, is amortized over the life of the instrument through periodic charges to interest expense.
Net Loss Per Common Share
Basic net loss per common share is computed
by dividing net loss by the weighted-average number of common shares outstanding during the period. Potential common stock equivalents
are determined using the treasury stock method. For diluted net loss per share purposes, the Company excludes stock options and other
stock-based awards, including shares issued as a result of option exercises that are subject to repurchase by the Company, whose effect
would be anti-dilutive from the calculation. During the year ended December 31, 2021 and 2020, common stock equivalents were excluded
from the calculation of diluted net loss per common share, as their effect was anti-dilutive due to the net loss incurred. Therefore,
basic and diluted net loss per share was the same in all periods presented.
The Company had 154,518,887 and 28,443,298 potentially dilutive options
and convertible securities, respectively, that have been excluded from the computation of diluted weighted-average shares outstanding
as of December 31, 2021, and 223,237,026 and 26,694,516 potentially dilutive options and convertible securities, respectively, that have
been excluded from the computation of diluted weighted-average shares outstanding as of December 31, 2020, as they would be anti-dilutive.
Treasury Stock
The Company accounts for treasury stock under the
cost method and includes treasury stock as a component of stockholder’s deficit.
Fair Value of Financial Instruments
The guidance for fair value measurements, ASC 820,
Fair Value Measurements and Disclosures, establishes the authoritative definition of fair value, sets out a framework for measuring fair
value, and outlines the required disclosures regarding fair value measurements. Fair value is the price that would be received to sell
an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an
orderly transaction between market participants at the measurement date. The Company uses a three-tier fair value hierarchy based upon
observable and non-observable inputs as follow:
|
• |
Level 1 – Quoted market prices in active markets for identical assets and liabilities; |
|
• |
Level 2 – Inputs, other than level 1 inputs, either directly or indirectly observable; and |
|
• |
Level 3 – Unobservable inputs developed using internal estimates and assumptions (there is little or no market date) which reflect those that market participants would use. |
|
The Company records its derivative activities at
fair value. As of December 31, 2021, no derivative liabilities are recorded.
Off Balance Sheet Arrangements
The Company does not have any off-balance sheet arrangements.
Uncertain Tax Positions
The Company did not take any uncertain tax positions
and had no adjustments to unrecognized income tax liabilities or benefits pursuant to the provisions of Section 740-10-25 for the year
ended December 31, 2021.
Income
Taxes
The Company accounts for income taxes under Section
740-10-30 of the FASB Accounting Standards Codification. Deferred income tax assets and liabilities are determined based upon differences
between the financial reporting and tax basis of assets and liabilities and are measured using the enacted tax rates and laws that will
be in effect when the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management
concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted
tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.
The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the consolidated statements of operations
in the period that includes the enactment date.
Recent Accounting Pronouncements
The Company has reviewed all recently issued, but
not yet effective, accounting pronouncements, and does not believe the future adoption of any such pronouncements may be expected to cause
a material impact on its financial condition or the results of its operations.
The Company accounts for stock-based compensation
for employees and directors in accordance with Accounting Standards Codification 718, Compensation (“ASC 718”) as issued by
the FASB. ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the
statement of operations based on their fair values. Under the provisions of ASC 718, stock-based compensation costs are measured at the
grant date, based on the fair value of the award, and are recognized as an expense over the employee’s requisite service period
(generally the vesting period of the equity grant). The fair value of the Company’s common stock options are estimated using the
Black Scholes option-pricing model with the following assumptions: expected volatility, dividend rate, risk free interest rate and the
expected life. The Company expenses stock-based compensation by using the straight-line method. In accordance with ASC 718 and, excess
tax benefits realized from the exercise of stock-based awards are classified as cash flows from operating activities. All excess tax benefits
and tax deficiencies (including tax benefits of dividends on share-based payment awards) are recognized as income tax expense or benefit
in the condensed consolidated statements of operations. The Company accounts for stock-based compensation awards issued to non-employees
for services, as prescribed by ASC 718-10, at either the fair value of the services rendered or the instruments issued in exchange for
such services, whichever is more readily determinable, using the measurement date guidelines enumerated in Accounting Standards Update
(“ASU”) 2018-07.
In February 2016, the FASB issued ASU 2016-02, “Leases”
Topic 842, which amends the guidance in former ASC Topic 840, Leases. The new standard increases transparency and comparability
most significantly by requiring the recognition by lessees of right-of-use assets and lease liabilities on the balance sheet for all leases
longer than 12 months. Under the standard, disclosures are required to meet the objective of enabling users of financial statements to
assess the amount, timing, and uncertainty of cash flows arising from leases. For lessees, leases will be classified as finance or
operating, with classification affecting the pattern and classification of expense recognition in the income statement. The Company adopted
the new lease guidance effective January 1, 2019. The Company is not a party to any leases and therefore is not showing any asset
or liability related to leases in the current period or prior periods.
In November 2021, the FASB issued ASU 2021-10, Government
Assistance (Topic 832). The amendments within the update require certain disclosures about transactions with a government that are accounted
for by applying a grant or contribution accounting model by analogy. The amendments will require disclosure of information about the
nature of the transactions and the related accounting policy used to account for the transactions, information regarding the line items
within the consolidated financial statements that are affected by the transactions, and significant terms and conditions of the transactions.
The amendments in the update will be effective for financial statements issued for annual periods beginning after December 15, 2021,
with early adoption permitted. The Company does not believe the adoption of this ASU will have a material impact on the Company’s
consolidated financial statements or results of options.
ASC 740 prescribes a comprehensive model for how companies
should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on
a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the
position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as
the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority
assuming full knowledge of the position and relevant facts.
Subsequent Events
On January 20, 2022 the Company entered into a
purchase agreement with the former CEO of Real Brands Inc., Jerome Pearring. The Company sold certain intellectual property rights
and Real Brands Venture Group a wholly owned subsidiary with the assumption of certain liabilities related to the IP. The purchase
price is the assignment of 1,000,000 shares of series A preferred stock and waiver of any possible severance payments.
NOTE 3. ACCOUNTS RECEIVABLES AND ALLOWANCE FOR DOUBTFUL ACCOUNTS
At December 31, 2021 the Company has $898 in accounts
receivables. The Company did not have an allowance for doubtful accounts at December 31, 2021. The balance in the account was received
during the first quarter of 2022. The Company does not accrue interest receivable on past due accounts receivable.
NOTE 4. INVENTORY
At December 31, 2021 the inventory was written down to $0. The inventory
had not moved for over a year due to the pandemic and renovations to the facility. As a result, the inventory that was at the facility
was written off. Inventory is comprised of hemp oil in different phases of production to completion of final product. Products include
tinctures, creams and lotions. Inventory is valued at cost. No purchases of pre-packaged products or packaging material is included in
inventory. Pre-packaged products and packaging materials are expensed as incurred.
NOTE 5. DEPOSITS
The Company has a deposit in the amount of $530 with a utility company.
NOTE 6. PROPERTY AND EQUIPMENT
Property and equipment is comprised of a
building and land, building improvements and furniture and equipment.
The building and land were appraised at $475,000.
The building is being depreciated over 15 years on a straight-line basis starting October 1, 2021, the date the building improvements
were completed on the building. Depreciation expense on the building for the year ended December 31, 2021 was $7,917.
The Company made $121,411 in building improvements
and purchases of $26,588 in furniture and equipment during the year ended December 31, 2021. The Company made $644,412 in building improvements
during the year ended December 31, 2020. $135,000 of those improvements were in the form of CASH common stock valued at $0.50 per share.
Building improvements is being depreciated over 15 years commencing from the completion of the work, October 1, 2021. Depreciation expense
on building improvements for the year ended December 31, 2021 was $13,097.
Property and equipment are recorded at cost. Depreciation is computed using
the straight-line method over estimated useful lives of five years. On December 31, 2021 the Company wrote down the value of the equipment
to $0 because the equipment had been sitting idle for over a year resulting in a loss on disposal of assets of $385,989. The furniture
and equipment and related accumulated depreciation were removed from the books as of December 31, 2021. Depreciation expense on the property
and equipment for the year ended December 31, 2021, before it was written off was $146,522. Total depreciation expense for the year ended
December 31, 2021 was $167,536. Expenditures for repairs and maintenance are expensed as incurred.
| |
| |
|
| |
December 31, | |
December 31, |
| |
2021 | |
2020 |
| |
| |
|
Building | |
$ | 475,000 | | |
$ | 475,000 | |
Building Improvements | |
| 785,823 | | |
| 664,412 | |
Furniture and Equipment | |
| 752,553 | | |
| 739,459 | |
Gross fixed assets | |
| 2,013,376 | | |
| 1,878,871 | |
Less: Accumulated Depreciation | |
| 387,578 | | |
| 233,535 | |
Less: Impairments | |
| 385,989 | | |
| — | |
Net Fixed Assets | |
$ | 1,239,809 | | |
$ | 1,645,336 | |
| |
| | | |
| | |
NOTE 7. ACCOUNTS PAYABLE AND ACCRUED EXPENSES
Accounts payable and accrued expenses include
normal operating expenses, professional fees and costs remaining to be paid for the build out of the new facility. Included in accrued
expenses is a balance for ATS Indian Trace, LLC. ATS Indian Trace, LLC v. the Company was a civil action filed by ATS Indian Trace, LLC
in the Circuit Court of Broward County, Florida on July 22, 2015. On November 18, 2015, a (default) Final Judgement was entered in favor
of ATS Indian Trace, LLC and against the Company in the amount of $71,069.37. This judgement is currently outstanding and remains due
and owing. ATS Indian Trace, LLC has not taken any enforcement action against the Company for several years. The balance is included
in accrued expenses even though the Company does not expect to ever have to pay it.
| |
| |
|
| |
December 31, | |
December 31, |
| |
2021 | |
2020 |
| |
| |
|
Accounts payable | |
$ | 154,758 | | |
$ | 364,922 | |
Accrued expenses | |
| 344,410 | | |
| 240,946 | |
Accrued interest | |
| 7,330 | | |
| 6,691 | |
Credit cards payable | |
| 6,568 | | |
| 24,541 | |
Total payable and expenses | |
$ | 513,065 | | |
$ | 637,100 | |
NOTE 8. ACCRUED EXPENSES – RELATED PARTY
At December 31, 2021, accrued expenses related parties
was $402,347.
Such amount included, to its CEO,
Thom Kidrin, $242,308 in accrued salary and $16,525 in accrued interest on a loan with principal balance of $133,605 (see Note 9)
and an additional $31,500 in accrued interest on a convertible note from Worlds Inc., with a principal balance of $200,000 (see Note
10). In addition, the Company owed $100,000 to its CFO, Chris Ryan, $7,000 to Dr. Rammal and $5,014 to other employees.
NOTE 9. NOTES PAYABLE AND LOANS PAYABLE
On March 1, 2021, the Company was notified that the
$106,660 PPP loan was forgiven. On September 11, 2021, the Company was notified that the $36,825 PPP loan was forgiven.
As of December 31, 2021, the following notes were
outstanding:
Schedule of Outstanding Loans Payable
| |
| |
|
| |
Loan payable | |
Accrued interest |
Note to a consultant (12%) | |
| 7,250 | | |
| 7,330 | |
Mortgage payable (5.24%) | |
| 148,551 | | |
| — | |
Total | |
$ | 155,801 | | |
$ | 7,330 | |
Interest expense related to the note payable to consultant,
Endeavour, amounted to $639 for the year ended December 31, 2021 and 2020, respectively.
NOTE 10. LOAN PAYABLE – RELATED PARTY
A loan was provided by the CEO, Thom Kidrin, at an
interest rate of 7%. The loan balance at December 31, 2021 was $133,605 with accrued interest of $16,525.
NOTE 11. CONVERTIBLE NOTES PAYABLE - RELATED PARTY
The Company has issued a convertible note payable
related party in the amount of $200,000. The convertible note has a 7% annual interest rate and matured on October 15, 2021. Interest
and principal are payable at maturity. The note can be converted at any time and either all or part of the amount due into equity at a
price of $0.50 per share. If converted into common stock, the related party would own 1% of Company based upon the current number of shares
outstanding. The related party holding the convertible note is Worlds Inc. Messrs. Kidrin, Toboroff and Christos are Directors of Worlds
Inc. and Mr. Kidrin is the CEO and Mr. Ryan is the CFO of Worlds Inc. On October 15, 2021,
the convertible note was extended to October 15, 2023. All other terms remain the same. As consideration for extending the
maturity date two years, the Company is issuing one million warrants to purchase the Company’s stock at a purchase price $0.05 per
share. The Company recorded a warrant expense of $37,753 for the warrants granted with the extension.
As of December 31, 2021, the Company incurred $31,500
in interest expense on the convertible note.
NOTE
12. CONTINGENT LIABILITIES
TBG Holdings entered into an agreement with the Company
on or about October 16, 2012 for performance of services in exchange for money and stock. On December 5, 2013 TBG alleged that the Company
had breached the contract and made a demand upon the Company for payment of money damages and stock. The Company disputed the claim and
refused to comply with the demand. On January 4, 2014, TBG’s counsel renewed the demand and requested mediation. The Company refused
mediation and denied any liability. TBG never pursued a claim against the Company. This claim in the amount of $45,625 is listed as a
contingent liability on the books of the Company.
NOTE 13. STOCKHOLDER’S EQUITY
Common Stock
In the first quarter of 2021, the Company sold 55,372,219 shares with
net proceeds of $385,000 through private placements. In the second quarter of 2021, the Company sold 15,714,287 shares with net proceeds
of $550,000 through private placements. In the fourth quarter 2021, the Company sold 2,000,000 shares with net proceeds of $50,000 through
private placements. The Company issued 190,568,582 shares of common stock in 2021 that were subscribed for in 2020 but not issued in 2020.
In the year ended December 31, 2021, the Company issued
164,680,119 shares of common stock related to the reverse merger and 25,888,463 shares that were subscribed for in 2020, but not yet issued
at December 31, 2020.
As of December 31, 2021, the Company had 2,677,529,115
shares of its common stock outstanding, with 1,000,000 shares of its Series A preferred stock issued and outstanding.
Series A Preferred Stock
At December 31, 2021, an ex-officer of the Company
(pre-reverse merger) owns 100% of the outstanding series A preferred stock. The former officer owns 1,000,000 shares, which are all of
the issued and outstanding. Series A Preferred Shares have voting rights that carry a 100 common stock share vote for every Series A Preferred
Share. During the first quarter of 2022 the Company reacquired all of the Series A Preferred shares and retired them.
NOTE 14. STOCK OPTIONS
The Company has outstanding the following stock options as of December 31, 2021.
|
|
|
|
|
|
|
Exercise
Price per Share |
|
Shares
Under Option/warrant |
|
Remaining
Life in Years |
Outstanding |
|
|
|
|
$ |
0.011 |
|
|
|
4,000,000 |
|
|
|
3.50 |
|
$ |
0.0267 |
|
|
|
12,287,256 |
|
|
|
2.50 |
|
$ |
0.0267 |
|
|
|
92,154,421 |
|
|
|
4.00 |
|
$ |
0.0267 |
|
|
|
46,077,210 |
|
|
|
4.08 |
|
Total |
|
|
|
|
154,518,887 |
|
|
|
|
|
Exercisable |
|
|
|
|
|
|
|
|
|
|
$ |
0.011 |
|
|
|
4,000,000 |
|
|
|
3.50 |
|
$ |
0.0267 |
|
|
|
12,287,256 |
|
|
|
2.50 |
|
$ |
0.0267 |
|
|
|
92,154,421 |
|
|
|
4.00 |
|
$ |
0.0267 |
|
|
|
46,077,210 |
|
|
|
4.08 |
|
Total |
|
|
|
|
154,518,887 |
|
|
|
|
|
Five option holders exercised their options through
the cashless surrender clause in the option agreements. 55,093,631 shares of common stock were issued and 13,624,509 shares were surrendered
back to the Company during the year ended December 31, 2021.
During the year ended December 31, 2021, the
Company recorded a stock option expense of $1,065,390 representing the options that have fully vested.
NOTE 15. COMMITMENTS AND CONTINGENCIES
The Company is committed to an employment agreement
with Thom Kidrin, its President and CEO. Mr. Kidrin entered into the employment agreement with CASH on November 26, 2018. The employment
agreement provides for a base salary of $175,000 per year. Mr. Kidrin is entitled to participate in any stock, stock option or other equity
participation plan and any profit-sharing, pension, retirement, insurance, or other employee benefit plan generally available to the executive
officers of the Company.
CASH signed an Agreement and Plan of Merger with Purist
Acquisition LLC, Purist LLC and Michael S. Metcalfe (“MSM”). Upon consummation of the Merger, CASH will receive ownership
rights of all intellectual property related to Purist’s simulated moving bed chromatography technology and will be obligated to
the following payments: (i) A cash payment of $90,000, (ii) A certificate representing Seven Hundred Fifty Thousand (750,000) shares of
the Company’s Common Stock (or appropriate alternative arrangements if uncertificated shares of Seven Hundred Fifty Thousand (750,000)
shares of Company Common Stock represented by book-entry shares will be issued), (iii) A fully vested option to acquire One Hundred Fifty
Thousand (150,000) shares of the Company’s Common Stock (the “Option”). The Option shall be exercisable for three years
following the date the Company’s Common Stock becomes publicly traded through a stock exchange or is listed for trading through
an electronic quotation and trading service. The exercise price for the Option shall be the lower of (x) $0.50 per share or (y) the price
per share equal to a 25% discount of the offering price of the Company’s first public or private offering of its Common Stock following
the Closing which raises at least Five Hundred Thousand Dollars ($500,000), and (iv) An additional cash payment of Fifty Thousand Dollars
($50,000) to be paid as follows: Within thirty (30) days of its fiscal year end, the Company will deliver an amount equal to one (1%)
percent of its net income up to a maximum payment of Fifty Thousand Dollars ($50,000). In the event one (1%) percent of the
Company’s net income for the fiscal year ended
December 31, 2019, does not equal $50,000, then the process shall be repeated at the close of each successive fiscal year until such
time as an aggregate of Fifty Thousand Dollars ($50,000) has been delivered to MSM. In addition, on the Closing of the Merger, Company
shall enter into a consulting agreement with MSM providing for a monthly fee of $3,500 for a period of twelve (12) months. In connection
with his consultancy, MSM will enter into (1) an assignment of inventions agreement assigning ownership rights of all intellectual property
related to Purist’s simulated moving bed chromatography technology developed and/or created by MSM during the term of his consultancy
and (2) a non-competition agreement pursuant to which MSM will agree to not compete with the Company during the term of his consultancy
or within twelve (12) months after termination of his consultancy.
NOTE 16 - INCOME TAXES
At December 31, 2021, the Company had federal and
state net operating loss carry forwards of approximately $5,246,800 that expire in various years through the year 2041.
Due to net operating loss carry forwards and operating
losses, there is no provision for current federal or state income taxes for the years ended December 31, 2021 and 2020.
Deferred income taxes reflect the net tax effects
of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amount used for
federal and state income tax purposes.
The Company’s deferred tax asset at December
31, 2021 consists of net operating loss carry forwards calculated using federal and state effective tax rates equating to approximately
$1,364,168 less a valuation allowance in the amount of approximately $1,364,168. Because of the Company’s lack of earnings history,
the deferred tax asset has been fully offset by a valuation allowance. The valuation allowance increased by approximately $287,504 for
the year ended December 31, 2021 and increased by approximately $253,355 for the year ended December 31, 2020.
The
Company’s total deferred tax asset as of December 31, 2021, and 2020 are as follows:
Total Deferred Tax
| |
2021 | |
2020 |
Net operating loss carry forwards | |
| 5,246,800 | | |
| 4,141,015 | |
Valuation allowance | |
| (5,246,800 | ) | |
| (4,141,015 | ) |
Net deferred tax asset | |
| — | | |
| — | |
The reconciliation of income taxes computed at the federal and state statutory
income tax rate to total income taxes for the years ended December 31, 2021 and 2020 is as follows:
Reconciliation of Income Taxes
| |
2021 | |
2020 |
Income tax computed at the federal statutory rate | |
| 21 | % | |
| 21 | % |
Income tax computed at the state statutory rate | |
| 5 | % | |
| 5 | % |
Valuation allowance | |
| (26 | )% | |
| (26 | )% |
Total deferred tax asset | |
| — | | |
| — | |
On December 22, 2017, the 2017 Tax Cuts and Jobs
Act (the Tax Act) was enacted into law and the new legislation contains several key tax provisions that affected us, including a one-time
mandatory transition tax on accumulated foreign earnings and a reduction of the corporate income tax rate to 21% effective January 1,
2018, among others. We are required to recognize the effect of the tax law changes in the period of enactment, such as determining the
transition tax, remeasuring our U.S. deferred tax assets and liabilities as well as reassessing the net realizability of our deferred
tax asset and liabilities. In December 2017, the SEC staff issued Staff Accounting Bulletin No. 118, Income Tax Accounting Implications
of the Tax Cuts and Jobs Act (SAB 118), which allows us to record provisional amounts during a measurement period not to extend beyond
one year of the enactment date.
NOTE 17. SUBSEQUENT EVENTS
On
January 20, 2022 the Company entered into a purchase agreement with the former CEO of Real Brands Inc., Jerome Pearring. The Company
sold certain intellectual property rights and Real Brands Venture Group a wholly owned subsidiary with the assumption of certain liabilities
related to the IP. The purchase price is the assignment of 1,000,000 shares of series A preferred stock and waiver of any possible severance
payments.
The Company evaluates events that have occurred after the balance sheet date but before the financial statements
are issued. Based upon the evaluation, the Company did not identify any additional recognized or non-recognized subsequent events that
would have required adjustment or disclosure in the financial statements, except as disclosed.